Organon Denmark ApS

CVR-no.: 41193093

Bredgade 6 3

1260 København K


Annual report

1 January 2024 - 31 December 2024

The annual report has been presented and approved on the company's general meeting the
16/05/2025
Gitte Schou Petersen
Chairman of general meeting

Company information

Reporting companyOrganon Denmark ApS
Bredgade 6 3
1260 København K
CVR-no.:41193093
Reporting period:01/01/2024 - 31/12/2024
AuditorPricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
Strandvejen 44
2900 Hellerup
DK Denmark
CVR-no.: 33771231
P-number:1016959517

Statement by Management

The Executive Board has today considered and adopted the Annual Report of Organon Denmark ApS for the financial year 1 January - 31 December 2024.

 

The Annual Report is prepared in accordance with the Danish Financial Statements Act.

 

In our opinion the Financial Statements give a true and fair view of the financial position at 31 December 2024 of the Company and of the results of the Company operations for 2024.

 

We recommend that the Annual Report be adopted at the Annual General Meeting.



Copenhagen, the 16/05/2025

Management
Gitte Schou Petersen
Isabel Vandenberk



Independent auditor’s report

To the Shareholder of Organon Denmark ApS

Opinion

In our opinion, the Financial Statements give a true and fair view of the financial position of the Company at 31 December 2024, and of the results of the Company’s operations for the financial year 1 January - 31 December 2024 in accordance with the Danish Financial Statements Act.

We have audited the Financial Statements of Organon Denmark ApS for the financial year 1 January - 31 December 2024, which comprise income statement, balance sheet, statement of changes in equity and notes, including a summary of significant accounting policies (“financial statements”).

Basis for Opinion

We conducted our audit in accordance with International Standards on Auditing (ISAs) and the additional requirements applicable in Denmark. Our responsibilities under those standards and requirements are further described in the Auditor’s Responsibilities for the Audit of the Financial Statements section of our report. We are independent of the Company in accordance with the International Ethics Standards Board for Accountants’ International Code of Ethics for Professional Accountants (IESBA Code) and the additional ethical requirements applicable in Denmark, and we have fulfilled our other ethical responsibilities in accordance with these requirements and the IESBA Code. We believe that the audit evidence we have obtained is sufficient and appropriate to provide a basis for our opinion.

Management’s responsibilities for the financial statements

Management is responsible for the preparation of Financial Statements that give a true and fair view in accordance with the Danish Financial Statements Act, and for such internal control as Management determines is necessary to enable the preparation of Financial Statements that are free from material misstatement, whether due to fraud or error.

In preparing the Financial Statements, Management is responsible for assessing the Company’s ability to continue as a going concern, disclosing, as applicable, matters related to going concern and using the going concern basis of accounting in preparing the Financial Statements unless Management either intends to liquidate the Company or to cease operations, or has no realistic alternative but to do so.

Auditor’s responsibilities for the audit of the financial statements

Our objectives are to obtain reasonable assurance about whether the Financial Statements as a whole are free from material misstatement, whether due to fraud or error, and to issue an auditor’s report that includes our opinion. Reasonable assurance is a high level of assurance, but is not a guarantee that an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark will always detect a material misstatement when it exists. Misstatements can arise from fraud or error and are considered material if, individually or in the aggregate, they could reasonably be expected to influence the economic decisions of users taken on the basis of these Financial Statements.

As part of an audit conducted in accordance with ISAs and the additional requirements applicable in Denmark, we exercise professional judgement and maintain professional skepticism throughout the audit. We also:

• Identify and assess the risks of material misstatement of the Financial Statements, whether due to fraud or error, design and perform audit procedures responsive to those risks, and obtain audit evidence that is sufficient and appropriate to provide a basis for our opinion. The risk of not detecting a material misstatement resulting from fraud is higher than for one resulting from error as fraud may involve collusion, forgery, intentional omissions, misrepresentations, or the override of internal control.

• Obtain an understanding of internal control relevant to the audit in order to design audit procedures that are appropriate in the circumstances, but not for the purpose of expressing an opinion on the effectiveness of the Company’s internal control.

• Evaluate the appropriateness of accounting policies used and the reasonableness of accounting estimates and related disclosures made by Management.

• Conclude on the appropriateness of Management’s use of the going concern basis of accounting in preparing the Financial Statements and, based on the audit evidence obtained, whether a material uncertainty exists related to events or conditions that may cast significant doubt on the Company’s ability to continue as a going concern. If we conclude that a material uncertainty exists, we are required to draw attention in our auditor’s report to the related disclosures in the Financial Statements or, if such disclosures are inadequate, to modify our opinion. Our conclusions are based on the audit evidence obtained up to the date of our auditor’s report. However, future events or conditions may cause the Company to cease to continue as a going concern.

• Evaluate the overall presentation, structure and contents of the Financial Statements, including the disclosures, and whether the financial statements represent the underlying transactions and events in a manner that gives a true and fair view.

We communicate with those charged with governance regarding, among other matters, the planned
scope and timing of the audit and significant audit findings, including any significant deficiencies in
internal control that we identify during our audit.



Copenhagen, the 16/05/2025



PricewaterhouseCoopers Statsautoriseret Revisionspartnerselskab
CVR-no.: 33771231
Thomas Lillemose Lauritsen, mne34342

Management’s Review

Key activities

The Company’s business is importing and selling pharmaceuticals to treat patients within Women’s health (reproductive health and contraceptives), Cardiovascular, Dermatology, Parkinson diseases and Migraine.

The Company, which is headquartered in Copenhagen, is a wholly owned subsidiary of OBS Human Health Holding B.V., Oss, Holland with registration number 75947293, which is part of the Group of which Organon & Co., Inc. 30 Hudson Street, Jersey City, NJ 07302, USA is the final parent company.


Accounting Policies

The annual report has been prepared in accordance with the regulation applying to Reporting class B.

The Annual Report of Organon Denmark ApS for 2024 has been prepared in accordance with provision of the Danish Financial Statements Act applying to enterprises of reporting class B as well as selected rules applying to reporting class C.

 

The Financial Statements for 2024 are presented in TDKK.

 

Change in accounting policies

 

The method for recognition and measurement of “Other operating income” has been changed for 2024. 

Previously, the amount included only the Mark Up Fee related to expenses recharged to Organon International, and the expenses which were recharged, were reduced in “Other external expenses” and “Staff expenses” expenses, respectively.

 

For 2024, “Other operating income” includes both the recharged expenses and the mark up fee.

The comparison amounts for 2023 have been updated accordingly.

The change has no impact on the result or equity.

 

Otherwise, the accounting policies applied remain unchanged from last year.

 

 

Recognition and measurement

 

Revenues are recognized in the income statement as earned. Furthermore, value adjustments of financial assets and liabilities measured at fair value or amortized cost are recognized. Moreover, all expenses incurred to achieve the earnings for the year are recognized in the income statement, including depreciation, amortization, impairment losses and provisions as well as reversals due to changed accounting estimates of amounts that have previously been recognized in the income statement.

 

Assets are recognized in the balance sheet when it is probable that future economic benefits attributable to the asset will flow to the Company, and the value of the asset can be measured reliably.

 

Liabilities are recognized in the balance sheet when it is probable that future economic benefits will flow out of the Company, and the value of the liability can be measured reliably.

 

Assets and liabilities are initially measured at cost. Subsequently, assets and liabilities are measured as described for each item below.

 

Translation policies

 

Transactions in foreign currencies are translated at the exchange rates at the dates of transaction.

Exchange differences arising due to differences between the transaction date rates and the rates at the dates of payment are recognized in financial income and expenses in the income statement.

 

Receivables, payables and other monetary items in foreign currencies that have not been settled at the balance sheet date are translated at the exchange rates at the balance sheet date. Any differences between the exchange rates at the balance sheet date and the rates at the time when the receivable or the debt arose are recognized in financial income and expenses in the income statement.

 

 

Income Statement

 

Revenue

 

Revenue from the sale of goods for resale and finished goods is recognized in the income statement when delivery and transfer of risk to the buyer have been made before year end.

 

Revenue is recognized exclusive of VAT and net of discounts relating to sales.

 

Other operating income

 

Other operating income comprise of expenses and mark-up on the Company's cluster expenses and research activities recharged to group companies.

 

Expenses for raw materials and consumables

 

Expenses for raw materials and consumables comprise the raw materials and consumables consumed to achieve revenue for the year.

 

Other external expenses

 

Other external expenses comprise indirect production costs and expenses for premises, sales and distribution as well as office expenses, etc.

 

Staff expenses

 

Staff expenses comprise of salaries, pension, employee benefits and social security expenses.

 

Amortization, depreciation and impairment losses

 

Amortization, depreciation and impairment losses comprise amortization, depreciation and impairment of property, plant and equipment.

 

Financial income and expenses

 

Financial income and expenses are recognized in the income statement at the amounts relating to the financial year. 

 

Tax on profit/loss for the year

 

Tax for the year consists of current tax for the year and changes in deferred tax for the year. The tax attributable to the profit for the year is recognized in the income statement, whereas the tax attributable to equity transactions is recognized directly in equity.

 

 

Balance Sheet

 

Property, plant and equipment

 

Property, plant and equipment are measured at cost less accumulated depreciation and less any accumulated impairment losses.

 

Cost comprises the cost of acquisition and expenses directly related to the acquisition up until the time when the asset is ready for use.

 

Depreciation based on cost reduced by any residual value is calculated on a straight-line basis over the expected useful lives of the assets, which are:

 

Leasehold improvements: 3 years

Other fixtures & equipment: 5 years

 

Depreciation period and residual value are reassessed annually.

 

Impairment of fixed assets

 

The carrying amounts of intangible assets and property, plant and equipment are reviewed on an annual basis to determine whether there is any indication of impairment other than that expressed by amortization and depreciation.

 

If so, the asset is written down to its lower recoverable amount.

 

Fixed asset investments

 

Fixed asset investments consist of other receivables.

 

Receivables

 

Receivables are measured in the balance sheet at amortized cost, which substantially corresponds to nominal value. Provisions for estimated bad debts are made.

 

Prepayments

 

Prepayments comprise prepaid expenses concerning prepaid rent and subscriptions.

 

 

Provisions

 

Provisions are recognized when - in consequence of an event occurred before or on the balance sheet date - the Company has a legal or constructive obligation and it is probable that economic benefits must be given up to settle the obligation.

 

Deferred tax assets and liabilities

 

Deferred income tax is measured using the balance sheet liability method in respect of temporary differences arising between the tax bases of assets and liabilities and their carrying amounts for financial reporting purposes on the basis of the intended use of the asset and settlement of the liability, respectively.

Deferred tax assets are measured at the value at which the asset is expected to be realized, either by elimination in tax on future earnings or by set-off against deferred tax liabilities.

Deferred tax is measured on the basis of the tax rules and tax rates that will be effective under the legislation at the balance sheet date when the deferred tax is expected to crystallize as current tax. Any changes in deferred tax due to changes to tax rates are recognized in the income statement or in equity if the deferred tax relates to items recognized in equity.

 

Current tax receivables and liabilities

Current tax liabilities and receivables are recognized in the balance sheet as the expected taxable incomefor the year adjusted for tax on taxable income for prior years and tax paid on account. Extra paymentsand repayment under the on-account taxation scheme are recognized in the income statement in financialincome and expenses.

 

Financial debts

 

Debts are measured at amortized cost, substantially corresponding to nominal value.

 

Income statement 1 Jan 2024 - 31 Dec 2024

Disclosure 2024 2023
DKK DKK
Revenue 74,127,000 63,900,000
Cost of sales -55,907,000 -47,305,000
Other operating income 1 13,620,000 14,290,000
External expenses -9,705,000 -9,558,000
Gross Result 22,135,000 21,327,000
     Wages and salaries -17,598,000 -16,033,000
     Post-employment benefit expense -1,579,000 -1,660,000
     Social security contributions -101,000 -101,000
Depreciation, amortisation expense and impairment losses of property, plant and equipment and intangible assets -72,000 -127,000
Profit (loss) from ordinary operating activities 2,785,000 3,406,000
Other finance income from group enterprises 546,000 539,000
Other finance income 15,000 19,000
     Sundry finance expenses -141,000 -106,000
Profit (loss) from ordinary activities before tax 3,205,000 3,858,000
Tax expense -777,000 -934,000
Profit (loss) 2,428,000 2,924,000
Proposed distribution of results
Proposed dividend recognised in equity 0 4,000,000
Retained earnings 2,428,000 2,924,000
Proposed distribution of profit (loss) 2,428,000 2,924,000

Balance sheet 31 December 2024

Assets

Disclosure 2024 2023
DKK DKK
Leasehold improvements 0 38,000
Right of use assets 83,000 117,000
     Property, plant and equipment in progress 0
Property, plant and equipment 83,000 155,000
Other receivables 411,000 414,000
Investments 411,000 414,000
Total non-current assets 494,000 569,000
Trade receivables 27,852,000 21,122,000
Receivables from group enterprises 991,000 4,271,000
Current deferred tax assets 233,000 256,000
Other receivables 19,000 5,000
Deferred income assets 771,000 794,000
Receivables 29,866,000 26,448,000
Cash and cash equivalents 11,262,000 18,232,000
Current assets 41,128,000 44,680,000
Total assets 41,622,000 45,249,000

Balance sheet 31 December 2024

Liabilities and equity

Disclosure 2024 2023
DKK DKK
Paid contributed capital 40,000 40,000
Retained earnings 27,870,000 25,442,000
Proposed dividend 0 4,000,000
Total equity 27,910,000 29,482,000
Other provisions 977,000 1,069,000
Provisions, gross 977,000 1,069,000
Trade payables 1,776,000 1,144,000
Payables to group enterprises 4,891,000 6,219,000
Tax payables 594,000 1,051,000
Other payables, including tax payables, liabilities other than provisions 5,474,000 6,284,000
Short-term liabilities other than provisions, gross 12,735,000 14,698,000
Liabilities other than provisions, gross 12,735,000 14,698,000
Liabilities and equity, gross 41,622,000 45,249,000

Disclosures

1. Other operating income

  2024 2023
  kr. kr.
Expenses recharged to affiliated companies 13033000 13621000
Mark up fees 587000 669000
     
  13620000 14290000
     

2. Information on average number of employees

2024
Average number of employees 15
false false false true Erhvervsstyrelsen Regnskab Basis 31/12/2023 01/01/2023 Auditor's report on audited financial statements false false false false Gitte Schou Petersen Sortemosevej 22 2730 Herlev 411930932024-01-012024-12-31 411930932024-01-012024-12-311 411930932024-01-012024-12-310 411930932024-01-012024-12-311 411930932024-01-012024-12-312 411930932023-01-012023-12-31 411930932024-12-31 411930932023-12-31 iso4217:DKK